2025-2034 Blood Screening Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Blood Screening Market Through 2025?
The scope of the blood screening industry has seen robust expansion throughout the preceding years, projected to increase from a valuation of $3.15 billion in 2024 to $3.44 billion in 2025, reflecting a compounded annual growth rate of 9.4%; this preceding period's upward trajectory is largely due to escalating demands for blood transfusions, the mounting incidence of infectious diseases capable of transmission, the implementation of various governmental mandates and benchmarks, a greater volume of blood being donated and gathered, and widespread anxiety concerning global health matters and worldwide outbreaks.

What's the Projected Size of the Global Blood Screening Market by 2029?
The blood screening market is projected for swift expansion in the forthcoming years, reaching a valuation of $5.33 billion by 2029, exhibiting an 11.5% compound annual growth rate. This projected upswing is fueled by several key factors, notably improvements in healthcare infrastructure, increased public health consciousness driven by awareness initiatives, progress in diagnosing infectious ailments, worldwide health worries, and enhanced preparedness for pandemics. Significant shifts shaping this market span an increase in infectious disease occurrences, a push towards automation and better efficiency, escalating requirements for blood transfusions, a concentrated emphasis on ensuring transfusion safety, and ongoing investigation into pathogen identification methods.

View the full report here:
https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Top Growth Drivers in the Blood Screening Industry: What's Accelerating the Market?
The rising incidence of communicable illnesses is forecasted to be a catalyst for the expansion of the blood screening sector in the future. Medical professionals frequently examine blood for signs of sickness by detecting particular antibodies produced in response to a pathogen, which assists in managing these infections, stopping onward spread between people, and preventing further infection within the treated patient. Illustratively, data from the National Center for Biotechnology Information, a US governmental body, showed in June 2022 that outpatient care for infectious diseases has nearly tripled over twenty years, moving from an 8 per 1,000 rate to 26 per 1,000; consequently, this surge in infectious disease occurrence is fueling the development of the blood screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9047&type=smp

What Trends Will Shape the Blood Screening Market Through 2029 and Beyond?
Leading firms within the blood screening sector are pioneering advancements like liquid biopsy techniques, aiming to significantly upgrade the timeliness of cancer identification, refine the oversight of ongoing treatments, and facilitate tailored medical strategies. This minimally invasive liquid biopsy involves examining bodily fluids, such as blood, to identify malignant cells or genetic evidence originating from malignancies. Specifically demonstrating this trend, Guardant Health, Inc., a biotechnology organization situated in the United States, introduced its Shield blood-based screening assay in November 2023. This Shield evaluation centers on scrutinizing circulating cell-free DNA (cfDNA) present in the circulation, material that serves as an indicator for the existence of colon or rectal tumors or potentially pre-cancerous lesions, by concentrating on specific modifications within DNA pieces shed into the blood from cancerous tissue.

What Are the Main Segments in the Blood Screening Market?
The blood screeningmarket covered in this report is segmented -

1) By Product: Reagents And Kits; Instruments; Software And Services
2) By Technology: Nucleic Acid Testing; Enzyme-Linked Immunosorbent Assay (ELISA); Rapid Tests; Western Blot Assays; Next-Generation Sequencing (NGS)
3) By End User: Blood Banks; Diagnostic Centers And Pathology Labs; Hospitals; Clinics; Ambulatory Surgical Centers (ASCs)

Subsegments:
1) By Reagents And Kits: Diagnostic Reagents; Testing Kits
2) By Instruments: Automated Analyzers; Manual Testing Equipment
3) By Software And Services: Laboratory Information Management Systems (LIMS); Data Analysis Software; Support And Consulting Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9047&type=smp

Which Top Companies are Driving Growth in the Blood Screening Market?
Major companies operating in the blood screening market include Abbott Laboratories, Grifols S.A., Becton dic*kinson and Company, F. Hoffmann-La Roche AG, bioMérieux S.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics Inc., Beckman Coulter Inc., Siemens Healthineers AG, GE Healthcare, DiaSorin S.p.A., Merck KGaA, PerkinElmer Inc., Bio-Techne Corporation, Roche Diagnostics GmbH, Danaher Corporation, Sysmex Corporation, Natera Inc., GenMark Diagnostics Inc., QIAGEN N.V., Hologic Inc., Luminex Corporation, Trinity Biotech plc, Fujirebio Inc., OraSure Technologies Inc., Immunetics Inc., Accelerate Diagnostics Inc., Cepheid Inc., T2 Biosystems Inc., Haemonetics Corporation, HTG Molecular Diagnostics Inc., Verax Biomedical Inc.

Which Regions Will Dominate the Blood Screening Market Through 2029?
North America was the largest region in the blood screening market in 2024. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9047

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.